Cite
APA Citation
Zhang, C., Atri, P., Nallasamy, P., Parte, S., Rauth, S., Nimmakayala, R. K., Marimuthu, S., Chirravuri-Venkata, R., Bhatia, R., Halder, S., Shah, A., Cox, J. L., Smith, L., Kumar, S., Foster, J. M., Kukreja, R. C., Seshacharyulu, P., Ponnusamy, M. P., & Batra, S. K. (2022). small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma. Cancer letters, 551, . http://access.bl.uk/ark:/81055/vdc_100168598213.0x000039